Lambda-free light chain: A serum marker of dengue disease via NS3 protease-mediated antibody cleavage

References

• Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013 Apr 25;496(7446):504–15. doi: 10.1038/nature12060
   PubMed Web of Science ®Google Scholar
• Guzman MG, Halstead SB, Artsob H, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S7–16. doi: 10.1038/nrmicro2460
   PubMed Web of Science ®Google Scholar
• St John AL, Rathore APS. Adaptive immune responses to primary and secondary dengue virus infections. Nat Rev Immunol. 2019 Apr;19(4):218–230. doi: 10.1038/s41577-019-0123-x
   PubMed Web of Science ®Google Scholar
• Screaton G, Mongkolsapaya J, Yacoub S, et al. New insights into the immunopathology and control of dengue virus infection. Nat Rev Immunol. 2015 Dec;15(12):745–759. doi: 10.1038/nri3916
   PubMed Web of Science ®Google Scholar
• Bhatt P, Sabeena SP, Varma M, et al. Current understanding of the pathogenesis of dengue virus infection. Curr Microbiol. 2021 Jan;78(1):17–32. doi: 10.1007/s00284-020-02284-w
   PubMed Web of Science ®Google Scholar
• World Health Organization. Dengue and severe dengue. Available from: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
   Google Scholar
• Bhole MV, Sadler R, Ramasamy K. Serum-free light-chain assay: clinical utility and limitations. Ann Clin Biochem. 2014 Sep;51(Pt 5):528–542. doi: 10.1177/0004563213518758
   PubMed Web of Science ®Google Scholar
• Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia. 2006 Sep;20(9):1467–1473. doi: 10.1038/sj.leu.2404284
   PubMed Web of Science ®Google Scholar
• Jenner E. Serum free light chains in clinical laboratory diagnostics. Clin Chim Acta. 2014 Jan 1;427:15–20. doi: 10.1016/j.cca.2013.08.018
   PubMed Web of Science ®Google Scholar
• Hepojoki J, Cabrera LE, Hepojoki S, et al. Hantavirus infection-induced B cell activation elevates free light chains levels in circulation. PLOS Pathog. 2021 Aug;17(8):e1009843. doi: 10.1371/journal.ppat.1009843
   PubMed Web of Science ®Google Scholar
• Malecka-Gieldowska M, Folta M, Wisniewska A, et al. Cell population data and serum polyclonal immunoglobulin free light chains in the assessment of COVID-19 severity. Viruses. 2021 Jul 15;13(7):1381. doi: 10.3390/v13071381
   PubMed Web of Science ®Google Scholar
• Guzman MG, Harris E. Dengue. Lancet (London, England). 2015 Jan 31;385(9966):453–465. doi: 10.1016/S0140-6736(14)60572-9
   PubMed Web of Science ®Google Scholar
• Perera R, Kuhn RJ. Structural proteomics of dengue virus. Curr Opin Microbiol. 2008 Aug;11(4):369–377. doi: 10.1016/j.mib.2008.06.004
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Kuhn RJ, Rossmann MG. A structural perspective of the flavivirus life cycle. Nat Rev Microbiol. 2005 Jan;3(1):13–22. doi: 10.1038/nrmicro1067
   PubMed Web of Science ®Google Scholar
• Yamshchikov VF, Compans RW. Formation of the flavivirus envelope: role of the viral NS2B-NS3 protease. J Virol. 1995 Apr;69(4):1995–2003. doi: 10.1128/jvi.69.4.1995-2003.1995
   PubMed Web of Science ®Google Scholar
• Yamshchikov VF, Trent DW, Compans RW. Upregulation of signalase processing and induction of prM-E secretion by the flavivirus NS2B-NS3 protease: roles of protease components. J Virol. 1997 Jun;71(6):4364–4371. doi: 10.1128/jvi.71.6.4364-4371.1997
   PubMed Web of Science ®Google Scholar
• Falgout B, Pethel M, Zhang YM, et al. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol. 1991 May;65(5):2467–2475. doi: 10.1128/jvi.65.5.2467-2475.1991
   PubMed Web of Science ®Google Scholar
• Rodriguez-Madoz JR, Belicha-Villanueva A, Bernal-Rubio D, et al. Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol. 2010 Oct;84(19):9760–9774. doi: 10.1128/JVI.01051-10
   PubMed Web of Science ®Google Scholar
• Aguirre S, Maestre AM, Pagni S, et al. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLOS Pathog. 2012;8(10):e1002934.
   PubMed Web of Science ®Google Scholar
• Lin JC, Lin SC, Chen WY, et al. Dengue viral protease interaction with NF-kappaB inhibitor alpha/beta results in endothelial cell apoptosis and hemorrhage development. J Immunol. 2014 Aug 1;193(3):1258–1267. doi: 10.4049/jimmunol.1302675
   PubMed Web of Science ®Google Scholar
• Travis J, Potempa J. Bacterial proteinases as targets for the development of second-generation antibiotics. Biochim Biophys Acta. 2000 Mar 7;1477(1–2):35–50. doi: 10.1016/S0167-4838(99)00278-2
   PubMedGoogle Scholar
• von Pawel-Rammingen U, Johansson BP, Tapper H, et al. Streptococcus pyogenes and phagocytic killing. Nat Med. 2002 Oct;8(10):1044–1045. author reply 1045-6. doi: 10.1038/nm1002-1044
   PubMed Web of Science ®Google Scholar
• Wenig K, Chatwell L, von Pawel-Rammingen U, et al. Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17371–17376. doi: 10.1073/pnas.0407965101
   PubMed Web of Science ®Google Scholar
• Vindebro R, Spoerry C, von Pawel-Rammingen U. Rapid IgG heavy chain cleavage by the streptococcal IgG endopeptidase IdeS is mediated by IdeS monomers and is not due to enzyme dimerization. FEBS Lett. 2013 Jun 19;587(12):1818–1822. doi: 10.1016/j.febslet.2013.04.039
   PubMed Web of Science ®Google Scholar
• Leborgne C, Barbon E, Alexander JM, et al. IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies. Nat Med. 2020 Jul;26(7):1096–1101. doi: 10.1038/s41591-020-0911-7
   PubMed Web of Science ®Google Scholar
• Prokesova L, Potuznikova B, Potempa J, et al. Cleavage of human immunoglobulins by serine proteinase from staphylococcus aureus. Immunol Lett. 1992 Feb 15;31(3):259–265. doi: 10.1016/0165-2478(92)90124-7
   PubMed Web of Science ®Google Scholar
• Ryan MH, Petrone D, Nemeth JF, et al. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid. Mol Immunol. 2008 Apr;45(7):1837–1846. doi: 10.1016/j.molimm.2007.10.043
   PubMed Web of Science ®Google Scholar
• Siegel SJ, Weiser JN. Mechanisms of bacterial colonization of the respiratory tract. Annu Rev Microbiol. 2015;69(1):425–444. doi: 10.1146/annurev-micro-091014-104209
   PubMedGoogle Scholar
• World Health O. Dengue guidelines for diagnosis, treatment, prevention and control : new edition. Geneva: World Health Organization; 2009.
   Google Scholar
• Shiels MS, Landgren O, Costello R, et al. Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals. Clin Infect Dis. 2012 Nov 15;55(10):e103–8. doi: 10.1093/cid/cis692
   PubMed Web of Science ®Google Scholar
• Shen WF, Galula JU, Liu JH, et al. Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody. Elife. [2018 Oct 18];7. doi: 10.7554/eLife.38970
   Web of Science ®Google Scholar
• Renner M, Flanagan A, Dejnirattisai W, et al. Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus. Nat Immunol. 2018 Nov;19(11):1248–1256. doi: 10.1038/s41590-018-0227-7
   PubMed Web of Science ®Google Scholar
• Katzmann JA, Abraham RS, Dispenzieri A, et al. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Clin Chem. 2005 May;51(5):878–881. doi: 10.1373/clinchem.2004.046870
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Sequeira W, Kokebie R, et al. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity. Arthritis Care Res (Hoboken). 2011 Jun;63(6):891–898. doi: 10.1002/acr.20446
   PubMed Web of Science ®Google Scholar
• Bettacchioli E, Le Gaffric C, Mazeas M, et al. An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases. J Transl Autoimmun. 2021;4:100090. doi: 10.1016/j.jtauto.2021.100090
   PubMedGoogle Scholar
• Basile U, Napodano C, Pocino K, et al. Lack of association between vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders. Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8506–8514. doi: 10.26355/eurrev_201910_19164
   PubMed Web of Science ®Google Scholar
• Chen B, Wang W, Xu W, et al. Serum free light chain is associated with histological activity and cirrhosis in patients with chronic hepatitis B. Int Immunopharmacol. 2021 Oct;99:107881.
   PubMed Web of Science ®Google Scholar
• Deng X, Crowson CS, Rajkumar SV, et al. Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritis. J Rheumatol. 2015 Feb;42(2):181–187. doi: 10.3899/jrheum.140543
   PubMed Web of Science ®Google Scholar
• Virella G, Parkhouse RM. Papain sensitivity of heavy chain sub-classes in normal human IgG and localizaton of antigenic determinants for the sub-classes. Immunochemistry. 1971 Mar;8(3):243–250. doi: 10.1016/0019-2791(71)90478-2
   PubMedGoogle Scholar
• Turner MW, Bennich HH, Natvig JB. Pepsin digestion of human G-myeloma proteins of different subclasses. II. Immunochemical investigations of the products of peptic digestion. Clin Exp Immunol. 1970 Nov;7(5):627–640.
   PubMedGoogle Scholar
• Li H, Clum S, You S, et al. The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J Virol. 1999 Apr;73(4):3108–3116. doi: 10.1128/JVI.73.4.3108-3116.1999
   PubMed Web of Science ®Google Scholar
• Gandikota C, Gandhi L, Maisnam D, et al. A novel anti-NS2BNS3pro antibody-based indirect ELISA test for the diagnosis of dengue virus infections. J Med Virol. 2021 Jun;93(6):3312–3321. doi: 10.1002/jmv.26024
   PubMed Web of Science ®Google Scholar
• Jesús-González LA D, Cervantes-Salazar M, Reyes-Ruiz JM, et al. The nuclear pore complex: a target for NS3 protease of dengue and Zika Viruses. Viruses. 2020;12(6):583.
   PubMed Web of Science ®Google Scholar
• Palacios-Rapalo SN, De Jesus-Gonzalez LA, Reyes-Ruiz JM, et al. Nuclear localization of non-structural protein 3 (NS3) during dengue virus infection. Arch Virol. 2021 May;166(5):1439–1446. doi: 10.1007/s00705-021-05026-w
   PubMed Web of Science ®Google Scholar
• Khromykh AA, Varnavski AN, Sedlak PL, et al. Coupling between replication and packaging of flavivirus RNA: evidence derived from the use of DNA-based full-length cDNA clones of kunjin virus. J Virol. 2001 May;75(10):4633–4640. doi: 10.1128/JVI.75.10.4633-4640.2001
   PubMed Web of Science ®Google Scholar
• Patkar CG, Kuhn RJ. Yellow fever virus NS3 plays an essential role in virus assembly independent of its known enzymatic functions. J Virol. 2008 Apr;82(7):3342–3352. doi: 10.1128/JVI.02447-07
   PubMed Web of Science ®Google Scholar
• Gandikota C, Mohammed F, Gandhi L, et al. Mitochondrial import of dengue virus NS3 protease and cleavage of GrpEL1, a cochaperone of mitochondrial Hsp70. J Virol. 2020 Aug 17;94(17). doi: 10.1128/JVI.01178-20
   PubMed Web of Science ®Google Scholar